Pay in 4 interest-free payments of $5.13 Learn more
Ships within 48 hours · Estimated delivery Aug 11 - Aug 16
A low-dose GLP-1 approach may help reduce common side effects, such as nausea and digestive discomfort, especially for people who are sensitive to GI changes
SGLT-2 inhibitors or GLP-1 receptor agonists for adults with type 2 diabetes: a clinical practice guideline Practice Rapid Recommendations BMJ 2021
Featured Treatments: PT-141: A unique peptide that works directly on the nervous system to increase desire and arousal in both men and women, independent of the vascular system
Nauck MA, Petrie JR, Sesti G et al (2016) A phase 2, randomized, dose-finding study of the novel once-weekly human GLP-1 analog, semaglutide, compared with placebo and open-label liraglutide in patients with type 2 diabetes
Wegovy (semaglutide injection) available in Canada Franais News provided by Novo Nordisk Canada Inc
